Literature DB >> 6601651

Bactericidal effects of cefotetan and other antibiotics in human fluids.

R W Lacey, V L Lord, G L Howson.   

Abstract

Antibiotics were added at final concentrations of 0.5 to 10 mg/l to either human blood, serum, urine, bile or ascitic fluid inoculated with sensitive cultures. Bactericidal effects were monitored by estimation of viable counts over 24 h at 37 degrees C. Cefotetan was reliably bactericidal to bacteria suspended in human urine over a wide range of conditions. Gentamicin, cefotaxime, cefotetan and azthreonam were predominantly bactericidal against Enterobacteriaceae in serum and blood; gentamicin, cefotetan and cefotaxime were bactericidal in bile, and cefotetan bactericidal in ascitic fluid. The above antibiotics all also produced a bactericidal effect against Haemophilus influenzae in serum, and the macrolides erythromycin and rosaramicin destroyed haemophilus in serum more rapidly than did ampicillin or amoxycillin. In most of these fluids, destruction (reduction in viable counts by greater than 10-fold) of the inoculum occurred within 2 to 4 h for gentamicin and 4 to 6 h for similar concentrations of beta-lactam agents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601651     DOI: 10.1093/jac/11.suppl_a.125

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Serum bactericidal rate as measure of antibiotic interactions.

Authors:  L L Briceland; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

2.  Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve.

Authors:  J E Tisdale; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 3.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.